The first-line treatment regimens of peripheral T-cell lymphomas
10.3760/cma.j.issn.1009-9921.2013.09.021
- VernacularTitle:外周T细胞淋巴瘤的一线治疗
- Author:
Shiyong ZHOU
;
Shaohua WU
- Publication Type:Journal Article
- Keywords:
Peripheral T-cell;
Lymphomas,T-cell;
First-line treatment;
Prognosis
- From:
Journal of Leukemia & Lymphoma
2013;22(9):571-576
- CountryChina
- Language:Chinese
-
Abstract:
Peripheral T-cell lymphomas (PTCLs) are a kind of non-Hodgkin's lymphoma (NHL),which arise from heterogeneous mature T-lymphocyte and include a variety of different subtypes.Compared with B-cell lymphoma,PTCLs are characterized by a lower incidence,resistance to conventional chemotherapy,widespread dissemination,a higher recurrence rate and unfavorable prognosis.At present,the standard first-line treatment regimens have not yet been developed for PTCLs.Though,there are many studies and trials about new drugs and novel intensive regimens,which improve the clinical curative effects and prognosis of PTCL patients significantly.In this paper,the progress of first-line treatment regimens of patients with different PTCL subtypes was reviewed.
